---
$id: https://graph.org.ai/products/commodity/51111842
$type: Product
source: UNSPSC
code: "51111842"
title: "Degarelix"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Degarelix

**UNSPSC Code**: 51111842
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a gonadotropin releasing hormone inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SX0XJI3A11. European Medicines Agency schedules Degarelix in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB27748. Degarelix generally arises in the molecular formula C82H103CLN18O16. The term DEGARELIX is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, no. 3, 2002, list 48.) Most nations schedule degarelix under HS 29371900 and SITC 54154. As of Q4 2014, DEGARELIX remains the US FDA Preferred Term for this commodity. Degarelix bears US NLM identifiers UMLS ID C0971731 and NCI Concept Code C48385. SMILES: CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)N)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C4CC(=O)NC(=O)N4)NC(=O)C(CO)NC(=O)C(CC5=CN=CC=C5)NC(=O)C(CC6=CC=C(C=C6)Cl)NC(=O)C(CC7=CC8=CC=CC=C8C=C7)NC(=O)C.

